Concepts (210)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Academic Medical Centers
- Acantholysis
- Adaptor Proteins, Signal Transducing
- Adolescent
- Adrenal Cortex Hormones
- Adult
- Aged
- Aged, 80 and over
- Aminopyridines
- Anemia
- Animals
- Antibodies
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
- Antineoplastic Combined Chemotherapy Protocols
- Autoimmune Diseases
- B7-H1 Antigen
- Benzimidazoles
- Bevacizumab
- Biomarkers
- Biomarkers, Tumor
- Biopsy
- Brain
- Brain Neoplasms
- Cancer Care Facilities
- Cancer Vaccines
- Carbamates
- Carcinoma, Non-Small-Cell Lung
- CD8 Antigens
- Cell- and Tissue-Based Therapy
- Cell Line, Tumor
- Cell Transplantation
- Cell-Free Nucleic Acids
- Central Nervous System Neoplasms
- Chemotherapy, Adjuvant
- Chromosome Aberrations
- Chromosomes, Human, Pair 8
- Clinical Trials as Topic
- Clinical Trials, Phase I as Topic
- Clinical Trials, Phase II as Topic
- Clone Cells
- Cluster Analysis
- Cohort Studies
- Combined Modality Therapy
- Confidence Intervals
- Conjunctival Neoplasms
- CTLA-4 Antigen
- Cytokines
- Dendritic Cells
- Dermatitis
- Dermatomyositis
- Diagnostic Imaging
- Dietary Fiber
- Disease Management
- Disease Models, Animal
- Disease Progression
- Disease-Free Survival
- DNA Copy Number Variations
- DNA Mutational Analysis
- Dose-Response Relationship, Drug
- Dose-Response Relationship, Radiation
- Drug Administration Schedule
- Drug Eruptions
- Drug Resistance, Neoplasm
- Drug Synergism
- Drug Therapy, Combination
- Drug-Related Side Effects and Adverse Reactions
- Dyspnea
- Encephalitis
- Endothelial Cells
- Enterocolitis
- Enzyme Inhibitors
- Exanthema
- Fatal Outcome
- Fatigue
- Fatty Acids, Volatile
- Fecal Microbiota Transplantation
- Feces
- Female
- Fluorodeoxyglucose F18
- Follow-Up Studies
- Gastrointestinal Agents
- Gastrointestinal Microbiome
- Gene Dosage
- Gene Expression
- Gene Expression Profiling
- Gene Expression Regulation, Neoplastic
- Gene Rearrangement
- Genes, Neoplasm
- Genetic Predisposition to Disease
- Genome
- Genomics
- Health Status Indicators
- Heart
- Heart Neoplasms
- Hematopoiesis, Extramedullary
- Hospitalization
- Humans
- Imidazoles
- Immunity
- Immunohistochemistry
- Immunologic Factors
- Immunomodulation
| - Immunotherapy
- Immunotherapy, Adoptive
- In Situ Hybridization, Fluorescence
- Incidence
- Infliximab
- Injections, Spinal
- Interleukin-1beta
- Interleukin-9
- Ipilimumab
- Kaplan-Meier Estimate
- Lateral Ventricles
- Leukemia, Plasma Cell
- L-Lactate Dehydrogenase
- Lung Neoplasms
- Lymph Nodes
- Lymphatic Metastasis
- Lymphocyte Count
- Lymphocyte Depletion
- Lymphocytes, Tumor-Infiltrating
- Macrophages
- Magnetic Resonance Imaging
- Male
- MAP Kinase Kinase Kinases
- MAP Kinase Signaling System
- MART-1 Antigen
- Melanoma
- Melanoma, Experimental
- Meningeal Carcinomatosis
- Meningeal Neoplasms
- Metabolic Flux Analysis
- Metabolome
- Metagenome
- Mice
- Mice, Inbred C57BL
- Mice, Nude
- Middle Aged
- Mitogen-Activated Protein Kinase 1
- Mitogen-Activated Protein Kinase 3
- Mitogen-Activated Protein Kinases
- Mohs Surgery
- Molecular Targeted Therapy
- Monoclonal Gammopathy of Undetermined Significance
- Morpholines
- Multiple Myeloma
- Multivariate Analysis
- Mutation
- Necrosis
- Neoadjuvant Therapy
- Neoplasm Invasiveness
- Neoplasm Metastasis
- Neoplasm Proteins
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Neoplasms
- Neoplasms, Second Primary
- Neoplastic Cells, Circulating
- Oxidative Phosphorylation
- Oximes
- Palliative Care
- Patient Dropouts
- Phosphorylation
- Plasma Cells
- Plasmacytoma
- Polymorphism, Single Nucleotide
- Positron-Emission Tomography
- Probiotics
- Prognosis
- Programmed Cell Death 1 Receptor
- Proportional Hazards Models
- Prospective Studies
- Protein Kinase Inhibitors
- Proto-Oncogene Proteins B-raf
- Proto-Oncogene Proteins c-akt
- Proto-Oncogene Proteins c-myc
- PTEN Phosphohydrolase
- Pyridones
- Pyrimidinones
- Radiation Injuries
- Radiosurgery
- Randomized Controlled Trials as Topic
- Rare Diseases
- Response Evaluation Criteria in Solid Tumors
- Retrospective Studies
- Ribosomal Protein S6
- Risk Assessment
- Risk Factors
- Sequence Analysis, RNA
- Signal Transduction
- Skin Diseases, Vesiculobullous
- Skin Neoplasms
- Standard of Care
- Sulfonamides
- Survival Analysis
- Survival Rate
- Texas
- Time Factors
- T-Lymphocyte Subsets
- T-Lymphocytes
- Tongue Neoplasms
- Treatment Outcome
- Tumor Cells, Cultured
- Tumor Microenvironment
- Uveal Neoplasms
- Xenograft Model Antitumor Assays
- Young Adult
|
GLITZA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(116)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_